Unpublished studies

Scope: use to index descriptions of this information type, collections of unpublished information, how to identify unpublished studies or investigations of the contribution of unpublished material as an information type. Use where the tag ‘grey literature’ does not reflect or capture this information type because it is genuinely unpublished, perhaps because it is referred to by a third party or represents a conference presentation without an accessible abstract

Appraisal of: “Korevaar DA, Hooft L, Askie LM, Barbour V, Faure H, Gatsonis CA, et al. Facilitating Prospective Registration of Diagnostic Accuracy Studies: A STARD Initiative. Clin Chem. 2017;63: 1331–1341.”

Appraisal of: Wieseler B, Wolfram N, McGauran N et al. Completeness of reporting of patient-relevant clinical trial outcomes: comparison of unpublished clinical study reports with publicly available data. PLoS Med 2013;10(10):e1001526.

Appraisal of: Golder S, Loke YK. Sources of information on adverse effects. Health Info Libr J 2010;27:176-190.

Comments from the authors:
 
This publication is related to Su Golder’s PhD Thesis “Evaluating and Optimising the Retrieval of Research Evidence for Systematic Reviews of Adverse Drug Effects and Adverse Drug Reactions” from 2013. The thesis is available from http://etheses.whiterose.ac.uk/4749/

Appraisal of: Golder S, Loke YK, Bland M. Unpublished data can be of value in systematic reviews of adverse effects: methodological overview. J Clin Epidemiol 2010;63(10):1071-1081.

Comments from the authors:

Syndicate content